Skip to main content
Home
Conference
Abstracts & Posters 2024
Totally RAD Award Winner
Education & Resources
Articles & Publications
Past Conferences
RAVE Abstracts and Posters - June 2024
About
Contact
Home
Conference
Abstracts & Posters 2024
Totally RAD Award Winner
Education & Resources
Articles & Publications
Past Conferences
RAVE Abstracts and Posters - June 2024
About
Contact
Lebrikizumab in Combination with Topical Corticosteroids Improves Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis: Results from a Phase 3, Randomized, Double-Blinded, Placebo-Controlled Trial (ADhere)